A first-in-human phase 1 study Of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors (trial in progress) Meeting Abstract


Authors: Ray-Coquard, I. L.; O'Malley, D. M.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R. N.; Westin, S. N.; Lakhani, N.; McKean, W. B.; Koyama, T.; Kitano, S.; Lim, M. C.; Gomez-Roca, C. A.; Pérez-Fidalgo, A.; Curigliano, G.; Campone, M.; Sharkey, B.; Avsar, E.; Friedman, C.
Abstract Title: A first-in-human phase 1 study Of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors (trial in progress)
Meeting Title: ESGO 2025 Congress
Journal Title: International Journal of Gynecological Cancer
Volume: 35
Issue: 2 Suppl. 1
Meeting Dates: 2025 Feb 20-23
Meeting Location: Rome, Italy
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2025-02-01
Start Page: 101596
Language: English
ACCESSION: WOS:001546403600116
DOI: 10.1016/j.ijgc.2024.101596
PROVIDER: wos
Notes: Meeting Abstract: 300 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Claire Frances Friedman
    123 Friedman